高效连续流生产工艺

奕安济世生物药

奕安济世首席技术官黄光诚博士(Dr. Chris Hwang)受邀参加2022APM第三届亚洲制药产业大会并发表演讲，精彩内容可点击链接观看：
Industrialization of Highly Intensified Connected/Continuous Biomanufacturing Platform (HiCB) to Address Patient and Business Needs

Highlights:

- Integrate HiCB and novel facility design to provide flexibility, speed, high quality at low cost

- Platform designed to simplified PD while minimizing tech transfer, scale up and manufacturing risks

- Showcase implementation strategy and plan

奕安济世开发并整合了上游和下游连续化工艺平台。上游连续化的产率可达到行业领先的7g/L/d，累积可超100g/L。下游连续化工艺平台已开发完成并将在明年一季度正式投入GMP生产。奕安济世建有完善的模块化连续化生物制品生产工厂，拥有自主开发的高效益培养基，至今，奕安济世已成功完成GMP条件下多批次的50 - 300L规模的连续化生产，获得了中美临床申报批准。

君临沧海

奕安济世生物药

君临沧海 发表于 2023-1-11 12:40

https://www.hjbbio.com/ch/EventsDet/id-50.html

君临沧海

已阅，逼格很高

奕安济世生物药

君临沧海 发表于 2023-1-12 12:41
已阅，逼格很高

谢谢关注